Best Translational Medicines Service in India

OVERVIEWTranslational medicine, also known as translational cancer medicine, is a multidisciplinary approach that aims to improve the treatment response, survival rates, and quality of life of cancer patients. It involves transforming scientific discoveries into clinical applications. One of the crucial roles of translational medicine is to identify and study genetic abnormalities that cause cancers. This research provides oncologists with a better understanding of the disease, allowing them to develop efficient treatment protocols.

By making cancer care more targeted and personalised, translational medicine has led to the development of new anti-cancer medicines and targeted therapy protocols that have shown improved efficacy and reduced toxicity. As a result, it has a positive impact on the patient's recovery and quality of life.

Translational Medicine at HCG

Translational Medicine is driven by our patients, their diseases, and a quest to ethically do more than available Evidence-Based Medicine. It is a disruptive, yet systematic endeavour guided by a primary focus towards translational sciences spanning across the spectrum of molecular and cell biology to preclinical models to patient studies and back again, following the principles of critical path analysis and a six-sigma framework.

The Department of Translational Medicine and Therapeutics is equipped with an early-phase clinical trial centre, preclinical study capabilities, regulatory expertise, a clinical trial network, medical & scientific writing team and oncology analytics capabilities and works closely with genomic researchers and clinical scientists.


HCG's TMT department is a Centre of Excellence that accelerates oncology research and improves patient treatments and outcomes using a collaborative approach, from bench to bedside and vice-versa.


TMT at HCG aims to establish a sustainable research enterprise for outcome-based research. It offers cost-effective clinical and non-clinical development services, putting HCG on the world map of oncology research.


The department supports all the in-house basic and clinical translational research and has an international second opinion network for patient benefit worldwide. Apart from the in-house research activities the department functions as an interface with the Pharma-Biotech industry and makes HCG their preferred partner in oncology drug development programs across the product life cycles. The department has developed a close relationship with the "Indian Society for Clinical Research (ISCR)" as an Accredited Member Organisation of the society.

Below listed are our focus areas:

Translational oncology – solid tumours and haemato-oncology


Precision immunotherapy

Cell-based therapies

Microbiome interactions

Tumour microenvironment interactions

Translational pathology and digital pathology

Genomic theragnostics (genotype-guided cancer therapy)

Diagnostics development and drug screening

Cancer infections

Preventive oncology, community engagement and population science

Integrative oncology

Regenerative medicine

The Department of Translational Medicine (TMT) provides services that promote a vibrant translational research and training environment at HCG.

Translational Medicine Services

Early-phase Clinical Research Unit (CRU)

Early-phase oncology study design and data management

Internal and international second opinion solutions with a deep scientific dive into rare and recurrent cases

Investigator-initiated studies / real-world research

In-vitro and in-vivo non-clinical proof of concept studies/pharmacology studies

Biomarker research

Regulatory guidance and support

Scientific due diligence

Clinical data analysis

Medical and scientific writing

Research education and workforce development